Preparation method and application of T4 phage probe for displaying high-density HRP molecules

By knocking out the T4 phage soc and hoc genes and displaying the Avi-Tag biotinylated protein, a T4 phage probe bound to high-density HRP molecules was formed, which solved the problem of low probe sensitivity in the ELISA experiment, and achieved 16 times the detection sensitivity Improved and widely applicable ELISA detection methods.

CN119023948APending Publication Date: 2024-11-26YANGZHOU UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411189315.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-28
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In existing ELISA experiments, the probe sensitivity is low, the detection signal is weak, and it is difficult to effectively detect the presence of antigens or antibodies.

Method used

By knocking out the T4 phage soc and hoc genes, Avi-Tag is displayed and Hoc and Soc proteins are biotinylated to form a T4 phage probe bound to high-density HRP molecules, which significantly improves the sensitivity of the enzyme mark.

Benefits of technology

It significantly improves the sensitivity of ELISA detection and can work stably at room temperature. It is suitable for all pathogens that can be detected by ELISA, and the detection sensitivity is increased by 16 times.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119023948A_ABST
    Figure CN119023948A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method and application of a T4 bacteriophage probe for displaying high-density HRP molecules, the T4 bacteriophage probe can be combined with an antibody or an anti-antibody molecule, can display thousands of HRP molecules, and can be used as an enzyme-labeled secondary antibody in ELISA detection without changing the immunological characteristics of the antibody and affecting the biological activity of the probe. The detection sensitivity of the T4 bacteriophage probe is improved by 16 times compared with that of a traditional enzyme-labeled ELISA method, the T4 bacteriophage probe is good in stability at room temperature, reaction products are easy to appear, and the T4 bacteriophage probe is suitable for all pathogens capable of being detected through the ELISA detection method, so that the T4 bacteriophage probe is wider in applicability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a preparation method and application of a T4 phage probe displaying high-density HRP molecules, belonging to the technical field of phage probe preparation. Background Art

[0002] Phage display technology is a technology that precisely clones the coding gene or target gene fragment of a polypeptide or protein into a specific position of the phage coat protein structural gene to achieve fusion expression of the foreign polypeptide or protein with the coat protein. The display process does not interfere with the normal function of other coat proteins and can maintain their relatively independent spatial structure and biological activity, making it easier to recognize and bind to target molecules.

[0003] The T4 phage is mainly composed of three parts: the head, the tail, and the tail fiber. The head structure is mainly composed of the essential proteins gp23 (including 930 copies), gp24 (including 55 copies), and the non-essential proteins Hoc (including 155 copies) and Soc (including 870 copies). Hoc and Soc are symmetrically distributed on the surface of the phage icosahedron, with a high copy number. As non-essential genes for the growth of T4 phage, even if they are knocked out, they will not affect the proliferation of T4 phage in Escherichia coli. In vitro, exogenous peptides or proteins can be fused to the C-terminus of the Soc site and the N-terminus of the Hoc site, respectively, and bind to the surface of the T4 phage lacking Soc and Hoc with high affinity, thereby displaying the exogenous peptides or proteins on the T4△Soc△Hoc phage capsid. Therefore, exogenous proteins can be displayed on the surface of the T4 phage capsid by fusing with Hoc and Soc, thereby forming virus-like particles.

[0004] T4 phage in vitro assembly is a technique that simulates the natural assembly process of T4 phage in host cells under laboratory conditions. This method usually involves the following key steps:

[0005] 1. Preparation of phage capsid proteins: Purify the capsid proteins of T4 phage from Escherichia coli or other host cells, including essential proteins (such as gp23 and gp24) and non-essential proteins (such as Hoc and Soc).

[0006] 2. Exogenous protein fusion: The target exogenous protein is fused with the capsid protein (such as Hoc or Soc) for expression.

[0007] 3. Purify the fusion protein: Purify by affinity chromatography, ion exchange chromatography or size exclusion chromatography to obtain high-purity fusion protein.

[0008] 4. In vitro assembly: The purified fusion protein is mixed with other factors required for assembly (such as other capsid proteins, DNA, etc.), and the pH, ionic strength, temperature and other conditions are adjusted to induce the fusion protein to self-assemble into functional T4 phage-like particles.

[0009] 5. Particle identification: The assembled phage-like particles need to be identified by electron microscopy, SDS-PAGE analysis, Western blot and other methods to confirm the structure of the particles and the display of exogenous proteins.

[0010] 6. Functional verification: Use biological activity assays, binding experiments and other methods to verify whether the displayed exogenous protein maintains its original biological function.

[0011] The T4 phage in vitro assembly method has more advantages than the in vivo assembly method. The function and conformation of the recombinant protein can be analyzed before phage display, thus ensuring that the displayed protein retains its natural conformation and function.

[0012] Enzyme-linked immunosorbent assay (ELISA) is an immunoassay based on a multi-well plate. It can detect analytes quickly, quantitatively and sensitively at a relatively low cost. Its basic principle is that the enzyme molecule is covalently bound to the antibody or anti-antibody molecule. This binding does not change the immunological properties of the antibody, nor does it affect the biological activity of the enzyme. This enzyme-labeled antibody can specifically bind to the antigen or antibody adsorbed on the solid phase carrier. After the substrate solution is added, the substrate can change the hydrogen donor contained in it from a colorless reduced form to a colored oxidized form under the action of the enzyme, and a color reaction occurs. Therefore, the color reaction of the substrate can be used to determine whether there is a corresponding immune reaction, and the depth of the color reaction is proportional to the amount of the corresponding antibody or antigen in the specimen. This color reaction can be quantitatively measured by an ELISA detector. The probes used in current ELISA experiments have low sensitivity and weak detection signals. Summary of the invention

[0013] Purpose of the invention: The purpose of the present invention is to provide a method for preparing a T4 phage probe displaying high-density HRP molecules and its application. The T4 phage probe is used as an enzyme label carrier, and the surface-modified SA is universally combined with a biotinylated secondary antibody, which can significantly improve the enzyme label sensitivity in ELISA detection.

[0014] Technical solution: The present invention provides a method for preparing a T4 phage probe displaying high-density HRP molecules, characterized in that it comprises the following steps:

[0015] (1) Knock out the soc and hoc genes of wild-type T4 phage to construct T4△Soc△Hoc phage;

[0016] (2) Displaying Avi-Tag on Soc and Hoc capsid proteins, namely Hoc-AviTag and Soc-AviTag, and biotinylating them to form Hoc-Biotin and Soc-Biotin; the nucleotide sequence of the Hoc-AviTag is shown in SEQ NO.25, and the nucleotide sequence of the Soc-AviTag is shown in SEQ NO.26;

[0017] (3) Assemble T4△Soc△Hoc phage, Soc-Biotin and Hoc-Biotin to obtain T4@Biotin; then combine T4@Biotin and HRP@SA to obtain T4@Biotin@SA@HRP probe.

[0018] Furthermore, the construction process of step (1) is:

[0019] 1) Amplify the gRNA of the soc gene and the hoc gene, and insert them into the pTCPLS plasmid respectively to prepare pTCPLS-G-soc and pTCPLS-G-hoc; transform pTCPLS-G-soc and pTCPLS-G-hoc into Escherichia coli competent cells respectively, and extract the plasmids;

[0020] 2) Using wild-type T4 phage DNA as a template, the homology arm sequences containing the sequences on both sides of the soc and hoc genes were amplified; the amplified products were connected to the pTCPLS-G-soc and pTCPLS-G-hoc plasmids after restriction digestion to obtain pTCPLS-GD-soc and pTCPLS-GD-hoc recombinant plasmids; the recombinant plasmids were transformed into Escherichia coli competent cells, and positive bacteria were screened;

[0021] 3) The positive bacteria containing TCPLS-GD-soc and pTCPLS-GD-hoc recombinant plasmids and wild-type T4 phage were cultured on a medium containing arabinose and kanamycin, and the positive plaques were screened, namely T4△Soc△Hoc phage.

[0022] Furthermore, the nucleotide sequences of the primers used to amplify the gRNA of the soc gene are shown in SEQ NO.1-2; the nucleotide sequences of the primers used to amplify the gRNA of the hoc gene are shown in SEQ NO.3-4.

[0023] Furthermore, the nucleotide sequences of the primers used to amplify the homology arm sequences containing the sequences on both sides of the soc gene are shown in SEQ NOs.5 to 8; the nucleotide sequences of the primers used to amplify the homology arm sequences containing the sequences on both sides of the hoc gene are shown in SEQ NOs.9 to 12.

[0024] Furthermore, the specific process of step (2) is as follows:

[0025] 1) Amplify the Hoc-AviTag and Soc-AviTag fragments and connect them with the linearized NdeI / XhoI pET-28a plasmid, transform them into Escherichia coli competent cells, screen out positive monoclones with kanamycin resistance, induce expansion culture and purify them to obtain Hoc-AviTag and Soc-AviTag recombinant proteins;

[0026] 2) The Hoc-AviTag and Soc-AviTag recombinant proteins are mixed and cultured with biotin to obtain Hoc-Biotin and Soc-Biotin.

[0027] Furthermore, the nucleotide sequences of the primers used to amplify Hoc-AviTag are shown in SEQ NOs. 17-18, and the nucleotide sequences of the primers used to amplify Soc-AviTag are shown in SEQ NOs. 19-20.

[0028] Furthermore, in step (3), the molar ratio of Soc-Biotin, Hoc-Biotin, and T4ΔSocΔHoc phage particles is 5-30:10-30:1.

[0029] Furthermore, in step (3), the molar ratio of HRP@SA to T4@Biotin is 1000:1.

[0030] The present invention also provides a T4 phage probe prepared based on the above method.

[0031] The present invention also provides application of the T4 phage probe in antigen detection.

[0032] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: the T4 phage probe disclosed in the present invention can be covalently bound to antibodies or anti-antibody molecules, and can display thousands of HRP molecules. It can be used as an enzyme-labeled secondary antibody in ELISA detection without changing the immunological properties of the antibody or affecting the biological activity of the probe. The detection sensitivity of the T4 phage probe of the present invention is 16 times higher than that of the traditional enzyme-labeled ELISA method, and it has good stability at room temperature, and the reaction product is easy to show. Since the probe is suitable for all pathogens that can be detected by the ELISA detection method, it has a wider applicability. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 This is the agarose gel electrophoresis detection diagram of pTCPLS-G-soc / hoc described in the embodiment of the present invention; M: DL2000 molecular weight marker; 1-4: pTCPLS-G-soc; 5-8: pTCPLS-G-hoc;

[0034] Figure 2 This is an agarose gel electrophoresis detection diagram of pTCPLS-GD-soc / hoc described in the embodiment of the present invention. M: DL2000 molecular weight marker; 1-4: pTCPLS-GD-soc; 5-8: pTCPLS-GD-hoc;

[0035] Figure 3 This is the agarose gel electrophoresis detection diagram of T4ΔSoc described in the embodiment of the present invention. M: DL2000 marker; 1-2: T4ΔSocΔHoc; 3: wild type T4;

[0036] Figure 4 This is a graph of T4ΔSocΔHoc agarose gel electrophoresis detection described in the examples of the present invention. M: DL5000 marker; 1-7: T4ΔSocΔHoc; 8: wild-type T4;

[0037] Figure 5 The successful synthesis of T4ΔSocΔHoc was verified by SDS-PAGE as described in the present invention. Yellow: gp23 protein; Green: Hoc protein; Red: Soc protein.

[0038] Figure 6 This is the PCR electrophoresis diagram of the Hoc-AviTag positive plasmid described in the embodiment of the present invention, M: DL2000 marker; 1-5: Hoc-AviTag;

[0039] Figure 7 This is the PCR electrophoresis diagram of the Soc-AviTag positive plasmid described in the embodiment of the present invention, M: DL2000 marker; 1-6: Soc-AviTag;

[0040] Figure 8 The Hoc-AviTag purified by SDS-PAGE described in the present invention. M: molecular weight marker; 1: flow-through; 2-3: washing buffer; 4-6: eluent (250 mM imidazole);

[0041] Fig. 9 The purified Soc-AviTag identified by SDS-PAGE in the embodiment of the present invention. M: molecular weight marker; 1: flow-through; 2-3: washing buffer; 4-9: eluent (250 mM imidazole);

[0042] Fig.10 This is a Western Blot analysis diagram of the combination of Hoc-Biotin and HRP@SA described in the embodiment of the present invention;

[0043] Fig.11This is a Western Blot analysis diagram of the combination of Soc-Biotin and HRP@SA described in the embodiment of the present invention;

[0044] Fig.12 This is a diagram of the assembly of the Soc-AviTag fusion protein described in the examples of the present invention with phage particles at a specified molar ratio (1:1; 5:1; 10:1; 20:1; 30:1);

[0045] Fig.13 This is a diagram of the assembly of the Hoc-AviTag fusion protein described in the examples of the present invention with phage particles at a specified molar ratio (1:1; 5:1; 10:1; 20:1; 30:1);

[0046] Fig.14 This is an SDS-PAGE analysis diagram of the dual display of Hoc-Biotin and Soc-Biotin on T4ΔSocΔHoc described in the embodiment of the present invention. M: Marker; 1: Soc-AviTag; 2: Hoc-AviTag; 3: The first washing supernatant after the dual display of Hoc-Biotin and Soc-Biotin on T4ΔSocΔHoc; 4: The second washing supernatant after the dual display of Hoc-Biotin and Soc-Biotin on T4ΔSocΔHoc; 5: T4ΔSocΔHoc; 6: Hoc-AviTag and Soc-AviTag on T4ΔSocΔHoc; 7: SA modified with HRP is dually displayed on T4ΔSocΔHoc;

[0047] Fig.15 A positive control and a result diagram of the T4 phage probe assembled with HRP-modified streptavidin for indirect ELISA detection described in an embodiment of the present invention;

[0048] Fig.16 This is a blank control and negative control result diagram of an indirect ELISA test using a T4 phage probe assembled with HRP-modified streptavidin as described in an embodiment of the present invention. DETAILED DESCRIPTION

[0049] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.

[0050] Example 1: Knockout of wild-type T4 phage soc and hoc genes to successfully construct T4ΔSocΔHoc phage

[0051] CRISPR / Cas9 gRNAs targeting soc and hoc genes were designed using the Benchling online tool (Cloud-based platform for biotech R&D|Benchling). Primers for gRNA were designed and synthesized: soc-gRNA (SEQ NO.1-2, F: 5'-AGTTTGTGAACGTCAGAATAAAG-3', R: 5'-AACCTTT ATTCTGACGTTCACAA-3') and hoc-gRNA (SEQ NO.3-4, F: 5'-AGTGGCAGCAGT AAATTGAACTG-3', R: 5'-AACCAGTTCAATTTACTGCTGCC-3'). The specific transcription amplification steps are as follows: artificially synthesized gRNA-F / R was dissolved in pure water to a final concentration of 20 μM, 2.5 μL of each was taken, and mixed according to the following ratios (0.5 μL of T4 Polynucleotide Kinase, 1 μL of 10× buffer, 2.5 μL of gRNAF / R each, 1 μL of ATP (10 Mm) and 2.5 μL of ddH2O) were added and reacted at 37°C for 30 min. The mixture was placed in a beaker filled with boiling water, covered and naturally cooled to room temperature to complete primer annealing and form small fragments of dsDNA. The products were named soc-gRNA and hoc-gRNA. According to the method of Dong et al. (doi:10.3389 / fmicb.2023.1230775), the pTCP LS plasmid was linearized with SapI restriction enzyme, and the two annealed gRNAs were connected to the linearized pTCPLS plasmid to generate pTCPLS-G-soc and pTCPLS-G-hoc.

[0052] The recombinant pTCPLS-G-soc and pTCPLS-G-hoc plasmids were transformed into Escherichia coli DH5α competent cells by heat shock transformation. After overnight culture at 37°C, the pTCPLS-G-soc and pTCPLS-G-hoc plasmids were extracted using Fastpure Plasmid Mini Kit (Vazyme) and identified using primers gRNA-seq-pPT / Gseq-R-pPT (SEQ NO. 23-24) (see Figure 1 shown).

[0053] The wild-type T4 phage DNA was used as a template to amplify the homology arm sequence (~500 bp including the sequences on both sides of the soc and ho c genes). The PCR reaction system was: 25 μL of Phanta Max, 21 μL of ddH2O, and 1 μL of soc-up / down (SEQ NO.5-6 (F: 5'-TTTTTTTGGCGCGCCCGGGTCGACTCTACTGT TCCATCTCCCAT-3', R: 5'-TTTAAATAAAGGAGAATTACTAACTCAAGGACTCCTTC GG-3') and SEQ NO.7-8 (F: 5'-CCGAAGGAGTCCTTGAGTTAGTAATTCTCCTTTATT TAAA-3', R: 5'-GTAAACTTGGTCTGACAGCTCGAGCAAAATGCCATGGTTCTAGA-3')) or hoc-up / down (SEQ NO.9-10 (F: 5'-TTTTTTTGGCGCGCCCGGGTCGACGAGACTGATGGGTTATCTAT-3', R: 5'-GGCCGAAGCCCCTTATGAAAGTTATCCTTATT TTAATG-3') and 11-12 (F: 5'-CATTAAAATAAGGATAACTTTCATAAGGGGCTTCGGC C-3', R: 5'-GTAAACTTGGTCTGACAGCTCGAGCCAATCACCATCACGCTGAT-3')) and 2 μL of wild-type T4 phage DNA; amplification of all samples was carried out according to the following procedure: pre-denaturation at 95°C for 5 min, followed by 35 cycles (95°C for 30 s, 55°C for 30 s, 72°C for 1 min), and finally extension at 72°C for 10 min. The products amplified using primers soc-up / down and hoc-up / down were ligated to pTCPLS-G-soc and pTCPLS-G-hoc plasmids digested with restriction enzymes (AscI and XhoI) to construct pTCPLS-GD-soc and pTCPLS-GD-hoc recombinant plasmids. The pTCPLS-GD-soc and pTCPLS-GD-hoc plasmids were extracted using a kit, transformed into E. coli BL21 competent cells by electroporation, cultured at 37° overnight, and PCR amplified using primers gRNA-seq-pPT / Gseq-R-pPT (SEQNO.23-24) to screen positive E. coli BL21 containing recombinant plasmids pTCPLS-GD-soc and pTCPLS-GD-hoc (results as shown in Figure 2 shown).

[0054] 200 μL of E. coli BL21 (OD 600 0.4-0.6), wild-type T4 phage 10 4 PFU / mL), plated on LB solid agar plates containing 0.2% arabinose and a final concentration of 20 μg / mL kanamycin for selective growth. After overnight culture at 37°C, positive plaques were identified by polymerase chain reaction (PCR), and the detection primers were soc-de-F / R (SEQ NO.13-14) and hoc-de-F / R (SEQ NO.15-16). Wild-type T4 phage was used as template, and the PCR reaction system was: 25 μL of Phanta Max, 21 μL of ddH2O, 1 μL of primers soc-de-F / R or hoc-de-F / R and 2 μL of wild-type T4 phage; the amplification of all samples was carried out as follows: 95°C pre-denaturation for 5 min, followed by 35 cycles (95°C 30 s, 55°C 30 s, 72°C 1 min), and finally 72°C extension for 10 min. After PCR, sequencing and SDS-PAGE verification, the positive plaques were determined to be T4△Soc△Hoc phage ( Figure 3 , Figure 4 and Figure 5 ).

[0055] Example 2: Hoc-AviTag and Soc-AviTag were displayed on Soc and Hoc capsid proteins and biotinylated to form Hoc-Biotin and Soc-Biotin, and the effectiveness of the recombinant proteins was verified.

[0056] Figure 6 , 7 coli clones that were successfully transformed with the plasmid were selected and cultured again in 5 mL of LB medium containing 50 μg / mL kanamycin, and cultured overnight in a 37°C incubator at 220 rpm.

[0057] Dilute the overnight culture 1:100 into fresh LB medium until OD 600 Reached about 0.6-0.8. At the same time, a final concentration of 0.25mM isopropyl β-D-Thiogalactoside (IPTG) was added to induce the expression of the two recombinant proteins Hoc-AviTag and Soc-AviTag. After 4 hours, the induced cultured bacterial solution was harvested and centrifuged at 5,000rpm for 10 minutes. The cell pellet was resuspended in lysis buffer, then ultrasonically disrupted and centrifuged at 12,000rpm for 20 minutes. Hoc-AviTag and Soc-AviTag were obtained. The obtained Hoc-AviTag and Soc-AviTag supernatants were purified by Ni 2+ -NTA resin purification. The eluted proteins were identified by SDS-PAGE. The molecular weights of the two proteins were consistent with the prediction (Hoc-AviTag: ~41.4kDa, Soc-AviTag: 12.7kDa). They could also be biotinylated and linked to HRP@SA (e.g. Figure 8 , 9 shown).

[0058] Biotinylation of Hoc-AviTag and Soc-AviTag: In the presence of biotin and ATP, BirA rapidly catalyzes the attachment of biotin to the lysine residues of AviTag. The recombinant proteins Soc-AviTag and Hoc-AviTag were reacted with Biotin at a concentration of 40 μM at 30°C for 1 hour to complete the biotinylation process. The biotinylated Soc-AviTag and Hoc-AviTag were dialyzed in PBS buffer overnight to remove unbound Biotin, thereby obtaining Hoc-Biotin and Soc-Biotin.

[0059] In order to identify the effectiveness of Hoc-Biotin and Soc-Biotin. Hoc-Biotin and Soc-Biotin were transferred to PVDF membranes by wet blotting, respectively. The PVDF membrane was then incubated in TBST buffer containing 5% skim milk at room temperature for 2 hours, and then washed three times with TBST. After washing, the PVDF membrane was incubated overnight at 4°C with 1:2,000 diluted HRP@SA (HRP-modified streptavidin, purchased from Biotech Co., Ltd.). After three TBST washes, the results of identification using ECL substrate solution showed that both Hoc-Biotin and Soc-Biotin produced immune reaction bands corresponding to their own molecular weights on the PVDF membrane (Hoc-Biotin: ~41.4kDa, Soc-Biotin: 12.7kDa), indicating that the two recombinant proteins were successfully biotinylated and could bind to HRP@SA (such as Fig.10 , 11 shown).

[0060] Example 3

[0061] In vitro assembly of T4△Soc△Hoc phage and Hoc-Biotin, Soc-Biotin (such as Fig.12 , 13 As shown). Soc-Biotin was assembled with T4△Soc△Hoc phage particles at a specified molar ratio (1:1; 5:1; 10:1; 20:1; 30:1) at 37°C for 1 hour. The results showed that at a binding ratio of 5:1, Soc-Biotin binding to the Soc binding site saturated the number of proteins displayed on the phage surface; Hoc-Biotin fusion protein was assembled with phage particles at a specified molar ratio (1:1; 5:1; 10:1; 20:1; 30:1) at 37°C for 1 hour. The results showed that at a binding ratio of 10:1, Hoc-Biotin binding to the Hoc binding site saturated the number of proteins displayed on the phage surface. This step is to screen out the optimal molar ratio of Hoc-Biotin and Soc-Biotin binding to T4△Soc△Hoc phage.

[0062] The phage particles were assembled at a molar ratio of Soc-Biotin: Hoc-Biotin: T4△Soc△Hoc at 37°C for 1 h, and then dialyzed in a beaker containing 1 L of PBS (4°C). The solution was changed twice to remove unbound Hoc-Biotin and Soc-Biotin to obtain T4@Biotin.

[0063] Example 4: High affinity binding of HRP-modified streptavidin to biotin

[0064] The present invention includes high affinity binding of HRP-modified streptavidin to in vitro assembled T4@Biotin.

[0065] HRP@SA was combined with the in vitro assembled T4@Biotin at a molar ratio of 1000:1 at 37°C for 2 hours, followed by centrifugation at 20,000 g for 45 minutes. The precipitate was resuspended in sterile PBS and centrifuged under the same conditions to obtain the T4@Biotin@SA@HRP probe.

[0066] SDS-PAGE analysis was performed on the first and second washing supernatants of Soc-AviTag; Hoc-AviTag; T4ΔSocΔHoc dually displaying Hoc-Biotin and Soc-Biotin (i.e., T4@Biotin); T4ΔSocΔHoc; T4ΔSocΔHoc dually displaying Hoc-AviTag and Soc-AviTag; T4ΔSocΔHoc dually displaying HRP-modified SA (e.g., Fig.14 The results show that Hoc-Biotin and Soc-Biotin can be displayed on the surface of T4 phage capsid. Lane 7 shows that HRP modification is successful.

[0067] Example 5: Construction of an indirect ELISA detection method using a HRP-modified streptavidin-assembled T4 phage probe

[0068] This example is a specific application of the phage probe of the present invention in ELISA antigen detection, and a commercial enzyme-labeled secondary antibody is used as a positive control to compare the sensitivity difference between the two.

[0069] The experiment set up the experimental group, positive control group, negative control group and blank group:

[0070] Experimental group and positive control group: Use ELISA carbonate coating buffer to dilute the mouse primary antibody 1.5 mg / mL in different gradients of 2500 times, 5000 times, 10,000 times, 20,000 times, 40,000 times, 80,000 times, 160,000 times, and 320,000 times; add the diluted primary antibody to the eight rows of twelve wells of the 96-well ELISA plate from top to bottom, with 100 μL added to each well; cover the well plate, incubate overnight at 2-8°C, then aspirate the liquid in each well, and add 2 00μL PBST was added to wash the ELISA plate 5 times; after washing, the plate was inverted and tapped gently on absorbent paper to remove residual liquid (the following washing operations are the same); at room temperature, 200μL blocking buffer (5% skim milk) was then added to each well and blocked at room temperature for 2 hours; washed 5 times with PBST; 100μl of 2000-fold diluted (0.8g / mL) goat mouse antibody (secondary antibody) was added to each well of the plate in turn, incubated at room temperature for 2 hours, and then the ELISA plate was washed 5 times with PBST. Positive control group: HRP@SA diluted 1000 times, 5000 times, 10,000 times, 20,000 times, 40,000 times, and 80,000 times with blocking buffer was then added to the ELISA plate (each dilution gradient corresponds to eight experimental wells with different mouse primary antibody concentrations in a vertical column, and one group was repeated twice); experimental group: 100μL 10 11 PFU / mL, 10 10 PFU / mL, 10 9 PFU / mL, 10 8 PFU / mL, 10 7 PFU / mL, 10 6 PFU / mL of the T4@Biotin@SA@HRP probe prepared strictly according to Example 4 (each dilution gradient corresponds to a row of eight-well strips, and a group of experiments is repeated twice); the above two ELISA plates are placed at room temperature for 1-2 hours and then washed 5 times with PBST; then 100 μL of color development solution is added to each well of the two ELISA plates, and the color is developed for 15 minutes; then 50 μL of stop solution (2M) is added to each well, and finally the absorbance of each well is read with an ELISA reader.

[0071] Blank control group: Compared with the experimental group, PBS was used as the coating antigen in the first step, and the other steps were the same;

[0072] Negative control group: Compared with the experimental group, except that goat mouse antibody (secondary antibody) was not added to the ELISA plate (0.8 g / mL), the rest of the steps were the same.

[0073] The results show that the T4 phage probe in the present invention can display thousands of HRP molecules, thus significantly amplifying the ELISA detection signal and can replace the HRP-labeled secondary antibody in the traditional ELISA. In a specific embodiment, the traditional enzyme-labeled HRP@SA (positive control) is diluted 1,000 times before the signal can be detected when the antigen (mouse primary antibody) is diluted to 5,000 times. In contrast, the T4 phage probe constructed by the present invention can still detect the signal when the same antigen (mouse primary antibody) is diluted up to 80,000 times. Therefore, the detection sensitivity of the present invention is 16 times higher than that of the traditional enzyme-labeled ELISA method. In addition, the probe is suitable for all Biotin-labeled antibody sandwich ELISA detection methods and has a wide range of application potential (such as Fig.15 , 16 shown).

Claims

1. A method for preparing a T4 phage probe displaying high-density HRP molecules, characterized in that: The following steps are involved: (1) Knock out the soc and hoc genes of wild-type T4 phage to construct T4△Soc△Hoc phage; (2) Displaying Hoc-AviTag and Soc-AviTag on Soc and Hoc capsid proteins and biotinylating them to form Hoc-Biotin and Soc-Biotin; the nucleotide sequence of the Hoc-AviTag is shown in SEQ NO.25, and the nucleotide sequence of the Soc-AviTag is shown in SEQ NO.26; (3) Assemble T4△Soc△Hoc phage, Soc-Biotin and Hoc-Biotin to obtain T4@Biotin; then combine T4@Biotin and HRP@SA to obtain T4@Biotin@SA@HRP probe.

2. The method for preparing a T4 phage probe displaying high-density HRP molecules according to claim 1, characterized in that: The construction process of step (1) is: 1) Amplify the gRNA of the soc gene and the hoc gene, and insert them into the pTCPLS plasmid respectively to prepare pTCPLS-G-soc and pTCPLS-G-hoc; transform pTCPLS-G-soc and pTCPLS-G-hoc into Escherichia coli competent cells respectively, and extract the plasmids; 2) Using wild-type T4 phage DNA as a template, the homology arm sequences containing the sequences on both sides of the soc and hoc genes were amplified; the amplified products were connected to the pTCPLS-G-soc and pTCPLS-G-hoc plasmids after restriction digestion to obtain pTCPLS-GD-soc and pTCPLS-GD-hoc recombinant plasmids; the recombinant plasmids were transformed into Escherichia coli competent cells, and positive bacteria were screened; 3) The positive bacteria containing TCPLS-GD-soc and pTCPLS-GD-hoc recombinant plasmids and wild-type T4 phage were cultured on a medium containing arabinose and kanamycin, and the positive plaques were screened, namely T4△Soc△Hoc phage.

3. The method for preparing a T4 phage probe displaying high-density HRP molecules according to claim 2, characterized in that: The nucleotide sequences of the primers used to amplify the gRNA of the soc gene are shown in SEQ NO.1-2; the nucleotide sequences of the primers used to amplify the gRNA of the hoc gene are shown in SEQ NO.3-4.

4. The method for preparing a T4 phage probe displaying high-density HRP molecules according to claim 2, characterized in that: The nucleotide sequences of the primers used to amplify the homology arm sequences containing the sequences on both sides of the soc gene are shown in SEQ NOs.5 to 8; the nucleotide sequences of the primers used to amplify the homology arm sequences containing the sequences on both sides of the hoc gene are shown in SEQ NOs.9 to 12.

5. The method for preparing a T4 phage probe displaying high-density HRP molecules according to claim 1, characterized in that: The specific process of step (2) is as follows: 1) Amplify the Hoc-AviTag and Soc-AviTag fragments and connect them with the linearized NdeI / XhoI pET-28a plasmid, transform them into Escherichia coli competent cells, screen out positive monoclones with kanamycin resistance, induce expansion culture and purify them to obtain Hoc-AviTag and Soc-AviTag recombinant proteins; 2) The Hoc-AviTag and Soc-AviTag recombinant proteins are mixed and cultured with biotin to obtain Hoc-Biotin and Soc-Biotin.

6. The method for preparing a T4 phage probe displaying high-density HRP molecules according to claim 5, characterized in that: The nucleotide sequences of the primers used to amplify Hoc-AviTag are shown in SEQ NOs. 17-18, and the nucleotide sequences of the primers used to amplify Soc-AviTag are shown in SEQ NOs. 19-20.

7. The method for preparing a T4 phage probe displaying high-density HRP molecules according to claim 1, characterized in that: In step (3), the ratio of Soc-Biotin and Hoc-Biotin molecules to the Soc and Hoc binding sites of T4△Soc△Hoc phage is 5-30:10-30:

1.

8. The method for preparing a T4 phage probe displaying high-density HRP molecules according to claim 1, characterized in that: The molar ratio of HRP@SA to T4@Biotin in step (3) is 1000:

1.

9. A T4 phage probe prepared according to the method of any one of claims 1 to 8.

10. Use of the T4 phage probe according to claim 9 in antigen detection.

Citation Information

Cited By

  • Stream type digital immunoassay method for detecting low-abundance substance to be detected based on engineering bacteriophage

    CN120594817A